| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $530.1M | +11.7% |
| R&D Expense | $69.9M | -4.2% |
| SG&A Expense | $95.7M | -14.3% |
| Operating Income | $60.4M | +253.3% |
| Interest Expense | $7.9M | -35.5% |
| Pre-tax Income | $55.0M | +1033.2% |
| Income Tax | $17.2M | +823.5% |
| Net Income | $37.8M | +422.2% |
| EPS (Basic) | $0.23 | +360.0% |
| EPS (Diluted) | $0.23 | +475.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.5M | -32.3% |
| Accounts Receivable | $79.4M | +6.5% |
| Current Assets | $254.5M | -4.0% |
| Total Assets | $1.15B | -3.4% |
| Current Liabilities | $84.2M | +2.1% |
| Long-term Debt | $35.0M | -77.4% |
| Total Liabilities | $143.6M | -49.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $117.9M | -10.4% |
| Capital Expenditures | $1.8M | -9.7% |
| Investing Cash Flow | -$40.5M | -16.8% |
| Financing Cash Flow | -$116.4M | -97.8% |
| Free Cash Flow | $116.1M | -10.4% |
| Stockholders' Equity |
| $1.01B |
| +10.8% |